代谢性肝病:主要指导方针的摘要,并确定改进未来指导方针的机会
1Division of Endocrinology, Diabetes and Metabolism, University of Alabama at Birmingham, Birmingham, Alabama, USA.
与代谢功能障碍相关的脂肪性肝病 (MASLD) 和脂肪性肝炎 (MASH) 管理的临床指南有很大的不同. 本次审查比较了当前的指导方针,并提出了为更一致和公平的患者护理提供框架.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 胃肠病学 胃肠病学
- 内分泌学 在内分泌学.
背景情况:
- MASLD和MASH的临床治疗正在迅速发展,新的诊断和治疗方法正在出现.
- 多个专业协会已经发布了指导方针,但存在显著的异质性.
研究的目的:
- 系统地比较MASLD和MASH的主要当代指南.
- 确定共识领域和查,风险分层,治疗和监测的关键差异.
- 提出一个改善未来指导方针的框架.
主要方法:
- 系统地比较肝病学,胃肠病学,内分泌学和糖尿病学会的当代指南.
- 对方法论基础的分析,包括依赖试验衍生种群和非侵入性测试截止值.
- 讨论导致不同建议的因素,如主观证据解释和有限的成本/访问考虑.
主要成果:
- 针对目标人群,非侵入性测试门和治疗资格的指导方针存在实质性的异质性.
- 局限性包括依赖高度精选的试验群体和缺乏对头对头比较.
- 不同的建议受到证据解释,心脏代谢并发症考虑以及成本/获取因素的影响.
结论:
- 需要为MASLD和MASH管理提供更具适应性和客观性的指导框架.
- 未来的指导方针应该提高透明度,采用结果知情的门,并整合心脏代谢风险降低.
- 改进的指导方针对于优化现实世界的实施和确保公平护理至关重要.
更多相关视频
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Diseases of the Liver and Gallbladder
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
